Literature DB >> 29592851

Development of a provisional essential medicines list for children in Canada: consensus process.

Hannah Woods1, Efosa Oronsaye1, Anjli Bali1, Yathavan Rajakulasingam1, Taehoon Lee1, Norman Umali1, Eyal Cohen1, Yaron Finkelstein1, Martin Offringa1, Nav Persaud1.   

Abstract

BACKGROUND: Worldwide, many countries have developed a list of essential medicines for children to improve prescribing. We aimed to create an essential medicines list for children in Canada.
METHODS: We adapted the previously created preliminary list of essential medicines for adults in Canada and the WHO Model List of Essential Medicines for Children to create a provisional list of essential medicines for children in Canada. Canadian clinicians made suggestions for changes. Literature relevant to each suggestion was presented to clinician-scientists, who used a modified nominal group technique to make recommendations on the suggestions. Ontario Public Drug Programs prescription data were reviewed to identify commonly prescribed medications missing from the list. Literature relevant to these medications was shared with a clinician-scientist review panel to determine which should be added, and a revised list was developed.
RESULTS: A total of 76 items were removed from the list of essential medicines for adults in Canada because they were not indicated for use in children or were not relevant in the Canadian health care context; 7 medications were added to the child list based on Ontario Public Drugs Programs prescribing data and clinician-scientist review. Suggestions to add, remove or substitute medications were made by peer-reviewers and resulted in removal of 1 medication and replacement of 1 medication. The process produced a provisional list of 67 essential medications for children.
INTERPRETATION: A provisional list of 67 essential medicines for children was created through a peer-reviewed, multistep process based on current clinical evidence, Canadian clinical practice guidelines and historical prescribing data. It is publicly posted at http://cleanmeds.ca/. The list should be further developed based on wider input and should be continuously revised based on emerging evidence of the safety and effectiveness of these medicines in all pediatric age groups. Copyright 2018, Joule Inc. or its licensors.

Entities:  

Year:  2018        PMID: 29592851      PMCID: PMC5878944          DOI: 10.9778/cmajo.20170129

Source DB:  PubMed          Journal:  CMAJ Open        ISSN: 2291-0026


  12 in total

1.  Hospital formularies: need for continuous intervention.

Authors:  J Feely; R Chan; L Cocoman; K Mulpeter; P O'Connor
Journal:  BMJ       Date:  1990-01-06

2.  The influence of the Pharmaceutical Benefits Scheme (PBS) on inappropriate prescribing in Australian nursing homes.

Authors:  Michelle A King; Michael S Roberts
Journal:  Pharm World Sci       Date:  2007-02

3.  GRADE: an emerging consensus on rating quality of evidence and strength of recommendations.

Authors:  Gordon H Guyatt; Andrew D Oxman; Gunn E Vist; Regina Kunz; Yngve Falck-Ytter; Pablo Alonso-Coello; Holger J Schünemann
Journal:  BMJ       Date:  2008-04-26

4.  Do prescribing formularies help GPs prescribe from a narrower range of drugs? A controlled trial of the introduction of prescribing formularies for NSAIDs.

Authors:  A J Avery; B Walker; T Heron; S J Teasdale
Journal:  Br J Gen Pract       Date:  1997-12       Impact factor: 5.386

Review 5.  Developing a paediatric drug formulary for the Netherlands.

Authors:  Tjitske M van der Zanden; Saskia N de Wildt; Yves Liem; Martin Offringa; Matthijs de Hoog
Journal:  Arch Dis Child       Date:  2016-10-31       Impact factor: 3.791

6.  The case for an essential medicines list for Canada.

Authors:  Gina Eom; Paul Grootendorst; Jacalyn Duffin
Journal:  CMAJ       Date:  2016-06-13       Impact factor: 8.262

7.  Impact of a formulary on personal care homes in Manitoba.

Authors:  M R Yakabowich; G Keeley; P R Montgomery
Journal:  CMAJ       Date:  1994-05-15       Impact factor: 8.262

8.  A Comprehensive List of Items to be Included on a Pediatric Drug Monograph.

Authors:  Lauren E Kelly; Shinya Ito; David Woods; Anthony J Nunn; Carol Taketomo; Matthijs de Hoog; Martin Offringa
Journal:  J Pediatr Pharmacol Ther       Date:  2017 Jan-Feb

Review 9.  Methods of formal consensus in classification/diagnostic criteria and guideline development.

Authors:  Raj Nair; Rohit Aggarwal; Dinesh Khanna
Journal:  Semin Arthritis Rheum       Date:  2011-03-21       Impact factor: 5.532

Review 10.  Evidence-based assessment of adherence to medical treatments in pediatric psychology.

Authors:  Alexandra L Quittner; Avani C Modi; Kathleen L Lemanek; Carolyn E Ievers-Landis; Michael A Rapoff
Journal:  J Pediatr Psychol       Date:  2007-09-10
View more
  1 in total

1.  Patient Safety: A Deep Concern to Caregivers.

Authors:  A K Mohiuddin
Journal:  Innov Pharm       Date:  2019-08-31
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.